Home Data Calendar Blog

ZOM

Tables

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31

Common Stock Value 380.97 380.97 380.97 380.97 380.97 380.96 380.96 380.96 380.93 NA 377.97

Weighted Average Number Of Diluted Shares Outstanding 979.95 979.95 979.95 NA 979.95 979.90 979.90 NA 978.49 973.66 890.25

Weighted Average Number Of Shares Outstanding Basic 979.95 979.95 979.95 NA 979.95 979.90 979.90 NA 978.49 973.66 890.25

Earnings Per Share Basic -0.00 -0.01 -0.01 NA -0.01 -0.01 -0.00 NA -0.01 -0.01 -0.04

Earnings Per Share Diluted -0.00 -0.01 -0.01 NA -0.01 -0.01 -0.00 NA -0.01 -0.01 -0.04

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Common Stock Value	380.97	380.97	380.97	380.97	380.97	380.96	380.96	380.96	380.93	NA	377.97
Weighted Average Number Of Diluted Shares Outstanding	979.95	979.95	979.95	NA	979.95	979.90	979.90	NA	978.49	973.66	890.25
Weighted Average Number Of Shares Outstanding Basic	979.95	979.95	979.95	NA	979.95	979.90	979.90	NA	978.49	973.66	890.25
Earnings Per Share Basic	-0.00	-0.01	-0.01	NA	-0.01	-0.01	-0.00	NA	-0.01	-0.01	-0.04
Earnings Per Share Diluted	-0.00	-0.01	-0.01	NA	-0.01	-0.01	-0.00	NA	-0.01	-0.01	-0.04

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31

Revenue From Contract With Customer Excluding Assessed Tax 6.35 6.02 5.48 6.16 4.78 4.25 3.75 4.08 0.02 0.02 0.01

Revenue From Contract With Customer Including Assessed Tax 6.35 6.02 5.48 6.16 4.78 4.25 3.75 4.08 0.02 0.02 0.01

Revenues 6.35 6.02 5.48 6.16 4.78 4.25 3.75 4.08 0.02 0.02 0.01

Cost Of Revenue 1.99 1.97 1.65 1.86 1.22 1.21 0.99 1.02 0.02 0.04 0.01

Gross Profit 4.36 4.05 3.83 4.29 3.56 3.04 2.76 3.06 0.00 -0.02 0.01

Research And Development Expense 0.87 0.86 0.92 0.78 1.13 0.32 0.35 0.66 0.29 0.27 0.41

General And Administrative Expense 6.12 NA NA NA 5.15 NA NA NA NA NA NA

Selling General And Administrative Expense NA 9.93 10.43 8.65 9.02 8.60 6.72 8.16 6.12 5.04 3.47

Selling And Marketing Expense 3.33 NA NA NA 3.73 NA NA NA NA NA NA

Operating Income Loss -5.95 -6.74 -7.51 -5.14 -6.59 -5.88 -4.31 -5.76 -6.41 -5.33 -3.87

Interest Expense 0.06 0.06 0.05 NA NA NA NA 0.00 NA NA NA

Interest Income Expense Net NA NA NA NA NA NA 0.11 NA NA NA 0.06

Allocated Share Based Compensation Expense 1.67 1.73 1.76 1.44 1.92 2.49 2.04 2.59 1.44 1.78 1.28

Income Tax Expense Benefit -1.92 -0.08 0.21 -1.05 -0.66 -0.38 -0.28 NA NA NA NA

Other Comprehensive Income Loss Net Of Tax 0.23 -0.06 0.29 -0.02 -0.83 -0.04 0.05 NA NA NA NA

Net Income Loss -0.49 -5.25 -6.38 -2.81 -5.00 -5.27 -3.94 -3.29 -6.35 -4.71 -4.04

Comprehensive Income Net Of Tax -0.27 -5.30 -6.10 -2.83 -5.83 -5.31 -3.89 -3.29 -6.35 -4.71 -4.04

Net Income Loss Available To Common Stockholders Basic -0.49 -5.25 -6.38 NA -5.00 -5.27 -3.94 NA -6.35 -4.71 -36.08

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Revenue From Contract With Customer Excluding Assessed Tax	6.35	6.02	5.48	6.16	4.78	4.25	3.75	4.08	0.02	0.02	0.01
Revenue From Contract With Customer Including Assessed Tax	6.35	6.02	5.48	6.16	4.78	4.25	3.75	4.08	0.02	0.02	0.01
Revenues	6.35	6.02	5.48	6.16	4.78	4.25	3.75	4.08	0.02	0.02	0.01
Cost Of Revenue	1.99	1.97	1.65	1.86	1.22	1.21	0.99	1.02	0.02	0.04	0.01
Gross Profit	4.36	4.05	3.83	4.29	3.56	3.04	2.76	3.06	0.00	-0.02	0.01
Research And Development Expense	0.87	0.86	0.92	0.78	1.13	0.32	0.35	0.66	0.29	0.27	0.41
General And Administrative Expense	6.12	NA	NA	NA	5.15	NA	NA	NA	NA	NA	NA
Selling General And Administrative Expense	NA	9.93	10.43	8.65	9.02	8.60	6.72	8.16	6.12	5.04	3.47
Selling And Marketing Expense	3.33	NA	NA	NA	3.73	NA	NA	NA	NA	NA	NA
Operating Income Loss	-5.95	-6.74	-7.51	-5.14	-6.59	-5.88	-4.31	-5.76	-6.41	-5.33	-3.87
Interest Expense	0.06	0.06	0.05	NA	NA	NA	NA	0.00	NA	NA	NA
Interest Income Expense Net	NA	NA	NA	NA	NA	NA	0.11	NA	NA	NA	0.06
Allocated Share Based Compensation Expense	1.67	1.73	1.76	1.44	1.92	2.49	2.04	2.59	1.44	1.78	1.28
Income Tax Expense Benefit	-1.92	-0.08	0.21	-1.05	-0.66	-0.38	-0.28	NA	NA	NA	NA
Other Comprehensive Income Loss Net Of Tax	0.23	-0.06	0.29	-0.02	-0.83	-0.04	0.05	NA	NA	NA	NA
Net Income Loss	-0.49	-5.25	-6.38	-2.81	-5.00	-5.27	-3.94	-3.29	-6.35	-4.71	-4.04
Comprehensive Income Net Of Tax	-0.27	-5.30	-6.10	-2.83	-5.83	-5.31	-3.89	-3.29	-6.35	-4.71	-4.04
Net Income Loss Available To Common Stockholders Basic	-0.49	-5.25	-6.38	NA	-5.00	-5.27	-3.94	NA	-6.35	-4.71	-36.08

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31

Assets 275.05 274.78 279.60 279.61 282.30 275.48 277.99 280.40 277.50 NA 280.47

Liabilities 14.17 15.30 16.54 12.22 13.52 9.26 8.95 9.51 5.94 NA 2.94

Liabilities And Stockholders Equity 275.05 274.78 279.60 279.61 282.30 275.48 277.99 280.40 277.50 NA 280.47

Stockholders Equity 260.88 259.48 263.06 267.39 268.78 266.22 269.04 270.89 271.56 276.07 277.53

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Assets	275.05	274.78	279.60	279.61	282.30	275.48	277.99	280.40	277.50	NA	280.47
Liabilities	14.17	15.30	16.54	12.22	13.52	9.26	8.95	9.51	5.94	NA	2.94
Liabilities And Stockholders Equity	275.05	274.78	279.60	279.61	282.30	275.48	277.99	280.40	277.50	NA	280.47
Stockholders Equity	260.88	259.48	263.06	267.39	268.78	266.22	269.04	270.89	271.56	276.07	277.53

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31

Assets Current 115.39 139.62 130.16 123.50 127.10 194.63 198.45 200.41 274.73 NA 278.55

Cash And Cash Equivalents At Carrying Value 21.78 27.95 8.35 27.40 45.09 186.76 192.34 194.95 271.41 NA 276.60

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 21.78 27.95 8.35 27.40 45.09 186.76 192.34 194.95 271.41 276.21 276.60

Accounts Receivable Net Current 1.35 0.65 0.43 0.60 0.72 NA NA 0.32 0.01 NA 0.01

Inventory Net 3.74 3.63 2.74 2.75 2.40 4.82 3.61 2.85 1.42 NA 0.31

Inventory Finished Goods And Work In Process 0.50 0.68 0.45 0.18 0.17 0.32 0.11 0.14 NA NA NA

Inventory Raw Materials And Supplies 2.70 2.21 1.73 1.69 1.70 1.30 0.89 0.89 NA NA NA

Prepaid Expense And Other Assets Current 3.02 3.56 4.86 3.80 3.61 2.31 NA 1.84 NA NA NA

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Assets Current	115.39	139.62	130.16	123.50	127.10	194.63	198.45	200.41	274.73	NA	278.55
Cash And Cash Equivalents At Carrying Value	21.78	27.95	8.35	27.40	45.09	186.76	192.34	194.95	271.41	NA	276.60
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents	21.78	27.95	8.35	27.40	45.09	186.76	192.34	194.95	271.41	276.21	276.60
Accounts Receivable Net Current	1.35	0.65	0.43	0.60	0.72	NA	NA	0.32	0.01	NA	0.01
Inventory Net	3.74	3.63	2.74	2.75	2.40	4.82	3.61	2.85	1.42	NA	0.31
Inventory Finished Goods And Work In Process	0.50	0.68	0.45	0.18	0.17	0.32	0.11	0.14	NA	NA	NA
Inventory Raw Materials And Supplies	2.70	2.21	1.73	1.69	1.70	1.30	0.89	0.89	NA	NA	NA
Prepaid Expense And Other Assets Current	3.02	3.56	4.86	3.80	3.61	2.31	NA	1.84	NA	NA	NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31

Property Plant And Equipment Gross 10.07 8.90 8.24 8.09 7.85 2.72 2.32 2.09 1.51 NA 0.99

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 1.81 1.61 1.44 1.28 1.12 1.01 0.95 0.88 0.81 NA 0.70

Amortization Of Intangible Assets 1.40 1.29 1.20 1.08 1.04 0.76 0.74 0.74 0.05 0.04 0.04

Property Plant And Equipment Net 8.26 7.29 6.80 6.81 6.73 1.71 1.37 1.21 0.71 NA 0.29

Goodwill 73.77 63.98 63.98 63.98 64.23 43.29 43.29 43.29 NA NA NA

Intangible Assets Net Excluding Goodwill 56.93 48.07 48.43 41.80 42.78 32.10 32.44 33.52 0.47 NA 0.32

Finite Lived Intangible Assets Net 56.37 48.07 48.43 41.80 42.78 32.10 32.44 33.52 0.47 NA 0.32

Other Assets Noncurrent 0.85 0.27 0.27 0.27 0.27 0.27 0.27 0.27 NA NA NA

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Property Plant And Equipment Gross	10.07	8.90	8.24	8.09	7.85	2.72	2.32	2.09	1.51	NA	0.99
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment	1.81	1.61	1.44	1.28	1.12	1.01	0.95	0.88	0.81	NA	0.70
Amortization Of Intangible Assets	1.40	1.29	1.20	1.08	1.04	0.76	0.74	0.74	0.05	0.04	0.04
Property Plant And Equipment Net	8.26	7.29	6.80	6.81	6.73	1.71	1.37	1.21	0.71	NA	0.29
Goodwill	73.77	63.98	63.98	63.98	64.23	43.29	43.29	43.29	NA	NA	NA
Intangible Assets Net Excluding Goodwill	56.93	48.07	48.43	41.80	42.78	32.10	32.44	33.52	0.47	NA	0.32
Finite Lived Intangible Assets Net	56.37	48.07	48.43	41.80	42.78	32.10	32.44	33.52	0.47	NA	0.32
Other Assets Noncurrent	0.85	0.27	0.27	0.27	0.27	0.27	0.27	0.27	NA	NA	NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31

Liabilities Current 6.74 7.21 8.60 7.81 7.13 4.47 4.12 4.34 4.87 NA 1.96

Accounts Payable And Accrued Liabilities Current 5.60 6.14 7.42 6.70 6.24 3.49 3.11 3.23 4.46 NA 1.13

Other Liabilities Current 0.09 0.10 0.06 0.08 0.06 0.27 0.22 0.26 NA NA NA

Contract With Customer Liability Current 0.26 0.26 0.24 0.21 0.20 0.15 0.15 0.20 NA NA NA

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Liabilities Current	6.74	7.21	8.60	7.81	7.13	4.47	4.12	4.34	4.87	NA	1.96
Accounts Payable And Accrued Liabilities Current	5.60	6.14	7.42	6.70	6.24	3.49	3.11	3.23	4.46	NA	1.13
Other Liabilities Current	0.09	0.10	0.06	0.08	0.06	0.27	0.22	0.26	NA	NA	NA
Contract With Customer Liability Current	0.26	0.26	0.24	0.21	0.20	0.15	0.15	0.20	NA	NA	NA

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31

Deferred Income Tax Liabilities Net 1.00 1.25 1.25 1.25 2.25 3.05 3.43 3.71 NA NA NA

Other Liabilities Noncurrent 1.43 2.18 1.97 1.88 2.87 0.39 0.39 0.36 1.07 NA NA

Operating Lease Liability Noncurrent 1.07 0.78 0.94 1.10 1.06 1.18 0.85 0.96 1.07 NA 0.98

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Deferred Income Tax Liabilities Net	1.00	1.25	1.25	1.25	2.25	3.05	3.43	3.71	NA	NA	NA
Other Liabilities Noncurrent	1.43	2.18	1.97	1.88	2.87	0.39	0.39	0.36	1.07	NA	NA
Operating Lease Liability Noncurrent	1.07	0.78	0.94	1.10	1.06	1.18	0.85	0.96	1.07	NA	0.98

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31

Stockholders Equity 260.88 259.48 263.06 267.39 268.78 266.22 269.04 270.89 271.56 276.07 277.53

Common Stock Value 380.97 380.97 380.97 380.97 380.97 380.96 380.96 380.96 380.93 NA 377.97

Additional Paid In Capital Common Stock 28.82 27.16 25.43 23.67 22.23 13.85 11.35 9.31 6.73 NA 4.60

Retained Earnings Accumulated Deficit -148.53 -148.04 -142.79 -136.40 -133.60 -128.60 -123.33 -119.39 -116.10 NA -105.05

Accumulated Other Comprehensive Income Loss Net Of Tax -0.39 -0.61 -0.56 -0.84 -0.82 0.01 0.05 0.00 NA NA NA

Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1.67 1.73 1.76 1.44 1.92 2.49 2.04 2.59 1.44 1.78 1.28

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Stockholders Equity	260.88	259.48	263.06	267.39	268.78	266.22	269.04	270.89	271.56	276.07	277.53
Common Stock Value	380.97	380.97	380.97	380.97	380.97	380.96	380.96	380.96	380.93	NA	377.97
Additional Paid In Capital Common Stock	28.82	27.16	25.43	23.67	22.23	13.85	11.35	9.31	6.73	NA	4.60
Retained Earnings Accumulated Deficit	-148.53	-148.04	-142.79	-136.40	-133.60	-128.60	-123.33	-119.39	-116.10	NA	-105.05
Accumulated Other Comprehensive Income Loss Net Of Tax	-0.39	-0.61	-0.56	-0.84	-0.82	0.01	0.05	0.00	NA	NA	NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value	1.67	1.73	1.76	1.44	1.92	2.49	2.04	2.59	1.44	1.78	1.28

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31

Net Cash Provided By Used In Operating Activities -3.03 -3.68 -4.26 -2.38 -2.77 -4.05 -2.47 -4.90 -5.00 -1.74 -2.64

Net Cash Provided By Used In Investing Activities -3.12 23.32 -14.79 -15.35 -138.89 -1.44 -0.21 -71.58 -0.20 -0.12 -0.02

Net Cash Provided By Used In Financing Activities NA NA NA 0.00 NA NA NA 0.02 0.40 1.47 217.27

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Net Cash Provided By Used In Operating Activities	-3.03	-3.68	-4.26	-2.38	-2.77	-4.05	-2.47	-4.90	-5.00	-1.74	-2.64
Net Cash Provided By Used In Investing Activities	-3.12	23.32	-14.79	-15.35	-138.89	-1.44	-0.21	-71.58	-0.20	-0.12	-0.02
Net Cash Provided By Used In Financing Activities	NA	NA	NA	0.00	NA	NA	NA	0.02	0.40	1.47	217.27

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31

Net Cash Provided By Used In Operating Activities -3.03 -3.68 -4.26 -2.38 -2.77 -4.05 -2.47 -4.90 -5.00 -1.74 -2.64

Net Income Loss -0.49 -5.25 -6.38 -2.81 -5.00 -5.27 -3.94 -3.29 -6.35 -4.71 -4.04

Increase Decrease In Accounts Receivable 0.69 0.20 -0.14 -0.16 0.35 0.07 0.03 0.05 -0.01 -0.00 0.01

Increase Decrease In Inventories -0.21 0.83 0.73 0.37 1.06 1.57 1.00 -0.90 -2.67 0.48 0.31

Share Based Compensation 1.67 1.73 1.76 1.44 1.92 2.49 2.04 2.59 1.44 1.78 1.28

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Net Cash Provided By Used In Operating Activities	-3.03	-3.68	-4.26	-2.38	-2.77	-4.05	-2.47	-4.90	-5.00	-1.74	-2.64
Net Income Loss	-0.49	-5.25	-6.38	-2.81	-5.00	-5.27	-3.94	-3.29	-6.35	-4.71	-4.04
Increase Decrease In Accounts Receivable	0.69	0.20	-0.14	-0.16	0.35	0.07	0.03	0.05	-0.01	-0.00	0.01
Increase Decrease In Inventories	-0.21	0.83	0.73	0.37	1.06	1.57	1.00	-0.90	-2.67	0.48	0.31
Share Based Compensation	1.67	1.73	1.76	1.44	1.92	2.49	2.04	2.59	1.44	1.78	1.28

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31

Net Cash Provided By Used In Investing Activities -3.12 23.32 -14.79 -15.35 -138.89 -1.44 -0.21 -71.58 -0.20 -0.12 -0.02

Payments To Acquire Property Plant And Equipment 0.24 0.03 0.11 0.20 0.43 0.07 0.08 0.05 0.05 0.03 0.01

		2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Net Cash Provided By Used In Investing Activities		-3.12	23.32	-14.79	-15.35	-138.89	-1.44	-0.21	-71.58	-0.20	-0.12	-0.02
Payments To Acquire Property Plant And Equipment		0.24	0.03	0.11	0.20	0.43	0.07	0.08	0.05	0.05	0.03	0.01

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31

Net Cash Provided By Used In Financing Activities NA NA NA 0.00 NA NA NA 0.02 0.40 1.47 217.27

		2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Net Cash Provided By Used In Financing Activities		NA	NA	NA	0.00	NA	NA	NA	0.02	0.40	1.47	217.27

2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31

Revenues 6.35 6.02 5.48 6.16 4.78 4.25 3.75 4.08 0.02 0.02 0.01

Revenue From Contract With Customer Excluding Assessed Tax 6.35 6.02 5.48 6.16 4.78 4.25 3.75 4.08 0.02 0.02 0.01

Product And Service Other 0.01 0.03 0.02 NA 0.05 0.03 0.08 NA NA NA NA

Capital Revenue 1.85 1.96 1.71 NA 1.30 1.54 1.59 NA NA NA NA

Consumables Revenue 4.48 4.03 3.75 NA 3.42 2.67 0.06 NA NA NA 0.01

Extended Warranties And Services Revenue NA NA NA NA NA NA 0.07 NA NA NA NA

Instruments Revenue NA NA NA NA NA NA 1.59 NA NA NA NA

Trodes Revenue NA NA NA NA NA NA 1.95 NA NA NA NA

Product And Service Other, Therapeutics 0.01 0.03 0.02 -0.08 0.08 0.30 0.15 NA NA NA NA

Capital Revenue, Diagnostics 0.18 0.07 0.22 NA NA NA NA NA NA NA NA

Capital Revenue, Therapeutics 1.67 1.89 1.49 NA 1.30 1.54 1.59 NA NA NA NA

Consumables Revenue, Diagnostics 0.19 0.18 0.18 0.15 0.09 0.09 0.06 0.07 0.02 NA NA

Consumables Revenue, Therapeutics 4.29 3.85 3.57 1.06 1.01 2.58 1.95 NA NA NA NA

Instruments Revenue, Therapeutics NA NA NA 2.90 1.27 1.54 NA NA NA NA NA

Trodes Revenue, Therapeutics NA NA NA 2.14 2.32 2.31 NA NA NA NA NA

Diagnostics 0.37 0.25 0.40 0.15 0.09 0.09 0.06 0.07 0.02 0.02 NA

Therapeutics 5.98 5.77 5.08 6.01 4.68 4.15 3.69 NA NA 0.00 NA

Revenue From Contract With Customer Including Assessed Tax 6.35 6.02 5.48 6.16 4.78 4.25 3.75 4.08 0.02 0.02 0.01

	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31
Revenues	6.35	6.02	5.48	6.16	4.78	4.25	3.75	4.08	0.02	0.02	0.01
Revenue From Contract With Customer Excluding Assessed Tax	6.35	6.02	5.48	6.16	4.78	4.25	3.75	4.08	0.02	0.02	0.01
Product And Service Other	0.01	0.03	0.02	NA	0.05	0.03	0.08	NA	NA	NA	NA
Capital Revenue	1.85	1.96	1.71	NA	1.30	1.54	1.59	NA	NA	NA	NA
Consumables Revenue	4.48	4.03	3.75	NA	3.42	2.67	0.06	NA	NA	NA	0.01
Extended Warranties And Services Revenue	NA	NA	NA	NA	NA	NA	0.07	NA	NA	NA	NA
Instruments Revenue	NA	NA	NA	NA	NA	NA	1.59	NA	NA	NA	NA
Trodes Revenue	NA	NA	NA	NA	NA	NA	1.95	NA	NA	NA	NA
Product And Service Other, Therapeutics	0.01	0.03	0.02	-0.08	0.08	0.30	0.15	NA	NA	NA	NA
Capital Revenue, Diagnostics	0.18	0.07	0.22	NA	NA	NA	NA	NA	NA	NA	NA
Capital Revenue, Therapeutics	1.67	1.89	1.49	NA	1.30	1.54	1.59	NA	NA	NA	NA
Consumables Revenue, Diagnostics	0.19	0.18	0.18	0.15	0.09	0.09	0.06	0.07	0.02	NA	NA
Consumables Revenue, Therapeutics	4.29	3.85	3.57	1.06	1.01	2.58	1.95	NA	NA	NA	NA
Instruments Revenue, Therapeutics	NA	NA	NA	2.90	1.27	1.54	NA	NA	NA	NA	NA
Trodes Revenue, Therapeutics	NA	NA	NA	2.14	2.32	2.31	NA	NA	NA	NA	NA
Diagnostics	0.37	0.25	0.40	0.15	0.09	0.09	0.06	0.07	0.02	0.02	NA
Therapeutics	5.98	5.77	5.08	6.01	4.68	4.15	3.69	NA	NA	0.00	NA
Revenue From Contract With Customer Including Assessed Tax	6.35	6.02	5.48	6.16	4.78	4.25	3.75	4.08	0.02	0.02	0.01

Plots across concepts

IncomeStatement

Expenses

Balance Sheet

Assets

Current Assets

NonCurrent Assets

PropertyPlantAndEquipmentNet

Liabilities

Current Liabilities

Noncurrent Liabilities

Stockholders Equity

CashFlow

NetCashProvidedByUsedInOperatingActivities

NetCashProvidedByUsedInInvestingActivities

OperatingLeaseLiability

LesseeOperatingLeaseLiabilityPaymentsDue

FiniteLivedIntangibleAssets

AccountsReceivable

Line plots across dimensions of each concept

Cost Ratio
us-gaap:StatementBusinessSegments
(None,)

Gross Margin
us-gaap:StatementBusinessSegments
(None,)

TTM Greenblatt ROC
_
(None,)

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:StatementBusinessSegments
(None,)

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:StatementBusinessSegments
(None, 'zom:Therapeutics')

us-gaap:CostOfRevenue
us-gaap:StatementBusinessSegments
(None,)

us-gaap:GrossProfit
us-gaap:StatementBusinessSegments
(None,)

us-gaap:OperatingIncomeLoss
us-gaap:StatementBusinessSegments
(None,)

us-gaap:Assets
us-gaap:StatementGeographical
(None,)

us-gaap:Assets
us-gaap:StatementBusinessSegments
(None,)

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)

us-gaap:CashAndCashEquivalentsAtCarryingValue
us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
('us-gaap:FairValueMeasurementsRecurring', None)

us-gaap:InventoryNet
us-gaap:StatementBusinessSegments
(None,)

us-gaap:InventoryFinishedGoodsAndWorkInProcess
us-gaap:StatementBusinessSegments
(None,)

us-gaap:InventoryRawMaterialsAndSupplies
us-gaap:StatementBusinessSegments
(None,)

us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)